Medtronic

YTD

ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit.

CEO

Geoffrey Straub Martha

CEOGeoffrey Straub Martha

Employees

95,000

Employees95,000

Headquarters

Galway, Galway

HeadquartersGalway, Galway

Founded

2014

Founded2014

Employees

95,000

Employees95,000

MDT Key Statistics

Market cap

110.45B

Market cap110.45B

Price-Earnings ratio

25.61

Price-Earnings ratio25.61

Dividend yield

3.32%

Dividend yield3.32%

Average volume

6.62M

Average volume6.62M

High today

$86.12

High today$86.12

Low today

$83.98

Low today$83.98

Open price

$84.81

Open price$84.81

Volume

6.57M

Volume6.57M

52 Week high

$96.25

52 Week high$96.25

52 Week low

$75.96

52 Week low$75.96

MDT News

TipRanks 2d

Medtronic Poised for Growth: Buy Rating Affirmed Amid Strong Sales Outlook and Product Advancements

TD Cowen analyst Josh Jennings maintained a Buy rating on Medtronic (MDT – Research Report) yesterday and set a price target of $95.00. Protect Your Portfolio...

TipRanks 3d

Orchestra BioMed reports Q1 EPS (49c), consensus (48c)

Reports Q1 revenue $868k, consensus $522.33k. David Hochman, Chairman and CEO of Orchestra BioMed (OBIO), stated: “We continued to make meaningful progress duri...

Simply Wall St 5d

Weak Financial Prospects Seem To Be Dragging Down Medtronic plc Stock

It is hard to get excited after looking at Medtronic's (NYSE:MDT) recent performance, when its stock has declined 8.1% over the past three months. Given that st...

Analyst ratings

48%

of 33 ratings

Buy

48.5%

Hold

42.4%

Sell

9.1%

More MDT News

TipRanks 7d

Medtronic’s Strategic Growth and Pipeline Development Drive Buy Rating Amid Tariff Challenges

Analyst Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $100.00. Trav...

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.